CA1313342C - Woven medical fabric - Google Patents
Woven medical fabricInfo
- Publication number
- CA1313342C CA1313342C CA000583707A CA583707A CA1313342C CA 1313342 C CA1313342 C CA 1313342C CA 000583707 A CA000583707 A CA 000583707A CA 583707 A CA583707 A CA 583707A CA 1313342 C CA1313342 C CA 1313342C
- Authority
- CA
- Canada
- Prior art keywords
- fabric
- woven
- medical
- initially
- inda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
- D03D15/20—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads
- D03D15/283—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads synthetic polymer-based, e.g. polyamide or polyester fibres
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
- D03D15/50—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the properties of the yarns or threads
- D03D15/533—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the properties of the yarns or threads antistatic; electrically conductive
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/21—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/263—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acids; Salts or esters thereof
- D06M15/277—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acids; Salts or esters thereof containing fluorine
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2321/00—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D10B2321/04—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of halogenated hydrocarbons
- D10B2321/042—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of halogenated hydrocarbons polymers of fluorinated hydrocarbons, e.g. polytetrafluoroethene [PTFE]
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
- D10B2331/04—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyesters, e.g. polyethylene terephthalate [PET]
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/02—Bandages, dressings or absorbent pads
- D10B2509/022—Wound dressings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S428/00—Stock material or miscellaneous articles
- Y10S428/913—Material designed to be responsive to temperature, light, moisture
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S428/00—Stock material or miscellaneous articles
- Y10S428/92—Fire or heat protection feature
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/3154—Of fluorinated addition polymer from unsaturated monomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
- Y10T442/2164—Coating or impregnation specified as water repellent
- Y10T442/2189—Fluorocarbon containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
- Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
- Y10T442/2631—Coating or impregnation provides heat or fire protection
- Y10T442/2713—Halogen containing
Abstract
WOVEN MEDICAL FABRIC
ABSTRACT OF THE DISCLOSURE
Reusable, launderable, sterilizable medical barrier fabric tightly woven from 100% polyester fiber constructed of polyester yarn of from 50 to 150 denier, the sum of the ends and picks of at least 100 per linear inch, is treated with a flame-resistant, and water repellent finish. Medical garments, wraps and like sterilizable articles constructed of this fabric retain their desirable properties after repeated institutional launderings and/or steam sterilizations.
ABSTRACT OF THE DISCLOSURE
Reusable, launderable, sterilizable medical barrier fabric tightly woven from 100% polyester fiber constructed of polyester yarn of from 50 to 150 denier, the sum of the ends and picks of at least 100 per linear inch, is treated with a flame-resistant, and water repellent finish. Medical garments, wraps and like sterilizable articles constructed of this fabric retain their desirable properties after repeated institutional launderings and/or steam sterilizations.
Description
WOVEN MEDICAL F~BRIC
BACKGROUND OF 1~ INVENTION
This invention relates to medical fabrics, particularly fabric used to make surgical gowns, surgical scrub suits, sterilization wrappers (CSR
wrap), cover gowns, isolation gowns, hamper bags, jump suit, work aprons, laboratory coats and the like. The fabric is especially suited as a barrier to prevent or control the spread of infectious microorganisms. The invention also includes processes for making a woven medical fabric.
There are currently two types of medical fabrics -- disposable and reuseable. Disposable fabrics are typically constructed from nonwovens made from light weight synthetic fibers or synthetic fibers blended with natural fibers. Performance of disposable nonwoven fabrics in terms of liquid repellency and flame retardancy are quite acceptable. Reusable fabrics are woven and may be constructed from cotton or cotton/polyester blends of a high thread count to provide a physical barrier to prevent or reduce the spread of infectious materials and vectors. While reusable woven fabrics offer more comfort in terms of drapeability, breathability, transmission of heat and water vapor, stiffness, etc., and improved (reduced) cost per use, they lack the liquid repellency and flame retardancy the market has come to expect on the basis of experience with the disposables, especially after repeated launderings and/or steam (autoclave) sterilizations.
This invention provides a woven, reusable, 1313;~4Z
direct finished single layer medical fabric made of 100% pol~ester fiber. The fabric exhibits the desirable properties of both the nonwoven disposables and woven reusable fabrics. The fabric has very low lint or particle generation, is a barrier with improved alcohol repellency, improved soil and oil repellency, is a generally more robust, abrasion-resistant fabric, yet has a soft hand, antimicrobial and antistatic properties, flame resistant, increased repellency to water, yet durably finished to be fully launderable and, if necessary, also autoclave sterilizable for numerous cycles.
Procedures for finishing such fabric and finishing solutions for use in such procedures are also described.
DES~IPTION OE 1~ INVENTION
To be competitive in the marketplace, woven reusable surgical barrier fabrics must meet or exceed the current criteria for National Fire Protection Association (NFPA-99) and the Association of Operating Room Nurses (AORN) "Recommended Practices -Aseptic Barrier Material for Surgical Gowns and Drapes" used in constructing operating room wearing apparel, draping and gowning materials. To be effective, the fabric must be resistant to blood and aqueous fluid (resist liquid penetration); abrasion resistant to withstand continued reprocessing; lint free to reduce the number of particles and to reduce the dissemination of particles into the wound;
drapeable; sufficiently porous to eliminate heat buildup; and flame resistant. Reusable fabrics ~3133a~2 should withstand multiple laundering and, where necessary, sterilization (autoclaving) cycles;
non-abrasive and free of toxic ingredients and non-fast dyes; resistant to tears and punctures;
provide an effective barrier to microbes, preferably bacteriostatic in their own right; and the reusable material should maintain its integrity over its expected useful life.
The products of this invention, measured against the recommendations and standards listed above, have the following properties assessed initially and after 100 institutional laundering or laundering and sterilization cycles.
1. Hydrostatic resistance, a measure of the fabric's resistance to penetration by blood and aqueous solutions, is measured using the Suter hydrostatic resistance test. Preferably initial readings are at least 20.0 (absolute) and 10.0 after 100 cycles and preferably an initial reading of at least 35.0 and at least 20.0 after 100 cycles.
BACKGROUND OF 1~ INVENTION
This invention relates to medical fabrics, particularly fabric used to make surgical gowns, surgical scrub suits, sterilization wrappers (CSR
wrap), cover gowns, isolation gowns, hamper bags, jump suit, work aprons, laboratory coats and the like. The fabric is especially suited as a barrier to prevent or control the spread of infectious microorganisms. The invention also includes processes for making a woven medical fabric.
There are currently two types of medical fabrics -- disposable and reuseable. Disposable fabrics are typically constructed from nonwovens made from light weight synthetic fibers or synthetic fibers blended with natural fibers. Performance of disposable nonwoven fabrics in terms of liquid repellency and flame retardancy are quite acceptable. Reusable fabrics are woven and may be constructed from cotton or cotton/polyester blends of a high thread count to provide a physical barrier to prevent or reduce the spread of infectious materials and vectors. While reusable woven fabrics offer more comfort in terms of drapeability, breathability, transmission of heat and water vapor, stiffness, etc., and improved (reduced) cost per use, they lack the liquid repellency and flame retardancy the market has come to expect on the basis of experience with the disposables, especially after repeated launderings and/or steam (autoclave) sterilizations.
This invention provides a woven, reusable, 1313;~4Z
direct finished single layer medical fabric made of 100% pol~ester fiber. The fabric exhibits the desirable properties of both the nonwoven disposables and woven reusable fabrics. The fabric has very low lint or particle generation, is a barrier with improved alcohol repellency, improved soil and oil repellency, is a generally more robust, abrasion-resistant fabric, yet has a soft hand, antimicrobial and antistatic properties, flame resistant, increased repellency to water, yet durably finished to be fully launderable and, if necessary, also autoclave sterilizable for numerous cycles.
Procedures for finishing such fabric and finishing solutions for use in such procedures are also described.
DES~IPTION OE 1~ INVENTION
To be competitive in the marketplace, woven reusable surgical barrier fabrics must meet or exceed the current criteria for National Fire Protection Association (NFPA-99) and the Association of Operating Room Nurses (AORN) "Recommended Practices -Aseptic Barrier Material for Surgical Gowns and Drapes" used in constructing operating room wearing apparel, draping and gowning materials. To be effective, the fabric must be resistant to blood and aqueous fluid (resist liquid penetration); abrasion resistant to withstand continued reprocessing; lint free to reduce the number of particles and to reduce the dissemination of particles into the wound;
drapeable; sufficiently porous to eliminate heat buildup; and flame resistant. Reusable fabrics ~3133a~2 should withstand multiple laundering and, where necessary, sterilization (autoclaving) cycles;
non-abrasive and free of toxic ingredients and non-fast dyes; resistant to tears and punctures;
provide an effective barrier to microbes, preferably bacteriostatic in their own right; and the reusable material should maintain its integrity over its expected useful life.
The products of this invention, measured against the recommendations and standards listed above, have the following properties assessed initially and after 100 institutional laundering or laundering and sterilization cycles.
1. Hydrostatic resistance, a measure of the fabric's resistance to penetration by blood and aqueous solutions, is measured using the Suter hydrostatic resistance test. Preferably initial readings are at least 20.0 (absolute) and 10.0 after 100 cycles and preferably an initial reading of at least 35.0 and at least 20.0 after 100 cycles.
2. Linting -- barrier medical fabrics should be as lint free as possible to reduce the dissemination of lint particles into wounds and into the surrounding environment. Linting is measured by the International Nonwovens and Disposables Association (INDA) test 160-0-83 (1.0 micron, 10 minutes) with initial values of less than 5,000 lint particles and less than 2,000 lint particles after 100 laundering/
sterilizing cycles 3. Flame resistance is a desirable, but not an 13~3;~42 essential (in some cases) property of barrier fabrics. Flame resistance is measured according to NFPA 702. This test measures the time a material takes to burn up a 4S incline; a longer time indicates a less flammable fabric. The fabric must be classified by this test as Class II initially and following 100 laundry/sterilization cycles.
sterilizing cycles 3. Flame resistance is a desirable, but not an 13~3;~42 essential (in some cases) property of barrier fabrics. Flame resistance is measured according to NFPA 702. This test measures the time a material takes to burn up a 4S incline; a longer time indicates a less flammable fabric. The fabric must be classified by this test as Class II initially and following 100 laundry/sterilization cycles.
4. Oil repellency, an indicator of soil release properties, is measured according to INDA 80.8 with initial values in the 3-8 range, preferably about 4.
The fabric may lose its oil repellency as the fluorocarbon water repellent and other treating agents are leached out of the fabric over time.
The fabric may lose its oil repellency as the fluorocarbon water repellent and other treating agents are leached out of the fabric over time.
5. Steam penetration - while a high thread count, tightly woven fabric is desirable in medical fabrics for its barrier properties, the fabric must also be amenable to steam sterilization both initially and following 100 cycles. This is especially true of medical fabrics such as surgical gowns, sterilization wrappers, surgical drapes and covers and other fabric products used in a sterile environment.
6 Colorfast - when a fabric is dyed to provide an attractive nonglare color that minimizes distortion from reflected light, the dye must remain on the fabric, be crock free and retain its color (fastness) following multiple launderings and, optionally, steam sterilizations. The fabrics of this invention have a colorfastness following 50 cycles of at least 2.5 according to AATCC 8-1981.
13~3;~42 7. Antimicrobial activity of the fabric is assessed using CTM-0923. There is no growth initially, and preferably at least a 90% kill, and no growth after 100 cycles.
13~3;~42 7. Antimicrobial activity of the fabric is assessed using CTM-0923. There is no growth initially, and preferably at least a 90% kill, and no growth after 100 cycles.
8. Spray ratings - another way to assess water repellency is using the AATCC-22-1980 spray test in which the fabric initially has a water spray of an absolute value of at least 70 (on a scale 0 to 100).
Water resistance diminishes following multiple launderings eventually to 50.
Water resistance diminishes following multiple launderings eventually to 50.
9. Alcohol repellency is another desirable, but not essential, property and this is measured using INDA
80.9. Initial values should be an absolute value o at least 6 (on a scale of 0-lO) but can be expected to decrease following multiple launderings 10. Air permeability - Frazier method - is used to assess the barrier properties of the fabric usually during production. Air permeability of less than 5 initially and at most 10 cubic feet per minute per square foot of fabric sample at 0.5 inch water after 100 laundry cycles measured according to Federal Test Method FTM 5450.
-These and related properties may be assessedusing diverse testing methods and quantification procedures, and evaluations may be made following any given number of washing/drying or laundry/
sterilization cycles The medical fabric of this invention may have essentially two performance levels Medical garments 1313~42 or products subjected to institutional washing and drying operations constructed from medical fabrics of this invention are quite satisfactory and represent an advancement when their water repellency is a minimum of 20 as tested on Suter hydrostatic test AATCC 127 initially. Other types of medical products and apparel require a higher level (on the order of 30 cm Suter hydrostatic test) to provide a satisfactory level of repellency.
7 ~313;~42 After 100 laundering and autoclave sterilization cycles, these ~-alues are as follows:
Initial After 100 Cycles Linting 5000 Max. 2000 Max IINDA 160-0-83~
Flammability Clags II Class II
(NFPA 702~
* at least 3 0 I~NDA ~8.8) Antimicrobial Activity No Growth No Growth ICIM-0923) Klebsiella Pneumoniae Alcohol Repellency*
at least 6 0 (INDA 80.9) Suter Hydrostatic 20.0 10.00 IAATCC-127), cm.
Spray Rating at least 70 at least 50 I M TCC-22-1980) Frazier Air Permeability less than S less than 10 IFTM 5450) cfmYft ~ 1/2" H20 *
optional properties 1313~42 Fabric construction is important to a successful product. The medical fabric used in this invention is woven from 100% polyester filament yarn (nylon lacks durability and is unsuited to this invention) with an optimum, predetermined fabric density.
Fabric density is a function of the fabric construction in which yarn denier, number of ends and number of picks (thread count) per linear inch are the essential variables. For general purposes, the yarn denier will fall in the range of from 50 to 150 in combination with a sum of the ends and picks (sometimes called a "round count") of at least 100 per inch. The following Table will provide guidance for appropriate range of fabric construction.
Denier Ends Picks Max. 50 162 108 Min. 50 108 72 Max. 70 137 191 Min. 70 190 60 Max. 100 116 76 Min. 100 76 50 Max. 150 94 62 Min. 150 62 42 131~342 The woven fabric, prior to finishing, has a weight of from about 2 to 10 ounces per square yard, preferably 2 to 3 ounces per square yard with 2.5 the most desired value.
Prior to treating, we recommend washing, drying and otherwise removing any lint that may be attached to or embedded in the fabric.
The polyester woven fabric of appropriate construction is finished with a treatment bath which may be applied using any convenient textile finishing operation and textile finishing equipment. Our equipment and experiences are specific to applying the treatment from a pad bath followed by subsequent processing in open width as explained in more detail below. Other methods of application including spraying, brushing, exhaust, etc., readily recognized by those skilled in this art may be used.
In overview, the pad bath contains the following types of ingredients; some listed below are optional ingredients, as indicated:
~313342 _n~redientAmount Iwt. %l non-rewetting surfactant .OZ5 - 2.0 fluorocarbon water repellentZ.0 - 15.0 flame retardant ~.0 - 20.0 antimicrobial agent 0.5 - 5.0 antistatlc compound 0.5 - 10.0 citric acid 0.01 - 1.0 disperse dye 0.01 - 3.0 pad pickup ~o~fl 40 ~ 100%
*
optional 11 131~342 Components of the pad bath serve various purposes and are readily available from several commercial sources.
Surfactants, to lower the surface tension of the water, a major ingredient of the bath, suited to the invention are of the non-rewetting type. The following surfactants are suggested: fatty acid amines, Mykon NRW3 (Sequa); alcohols, Penetrant KB
(Burlington Industries, Chemical Division); nonionic emulsions, Alkanol 6112 and Avitex 2153 (DuPont).
The fluQrocarbon water repellent component is typically a dispersion of fluoropolymer in water (see generally Fluorine-Containing Polymers, Encyclopedia of Polymer Science & Technology, pp 179-203, Interscience, 1967, the disclosure of which is hereby incorporated by reference). The fluoropolymer component may be selected from a host of commercially available products including DuPont's Zonyl NWG, Zonyl NWN, Zepel 6700, and 3-M's FC-834, FC-461 and FC 232. It is the fluorocarbon component that provides the water and fluid repellency to the finished fabric. One will select a repellent fluorocarbon component that is compatible with the system, i.e., the other bath components and processing conditions, is economical and provides the required degree of liquid repellency. A wax extender for the fluorocarbon may be incorporated in the formulation as required.
Flame retardants may be included in the formulation to impart flame resistance to the treated fabric. A variety of flame retardants are commercially available for cotton, synthetic and cotton/synthetic blended fabrics We find those 131:~342 1ame retardants convenient that can be added to a single finish formulation and do not require a separate processing step or steps to attach the flame retardant to the fibers. A preferred class of flame retardants are the cyclic phosphonate esters, a group of known flame retardants as described in U.S. Patent Nos. 3,789,091 and 3,849,368. Antiblaze 19 and Antiblaze l9T are commercially available cyclic phosphonate ester flame retardants from Albright &
Wilson. Other flame retardants suitable for this invention are Glo-Tard NTB (Glo-Tex) and Flameproof #1525 (Apex); all are organophosphates.
An antimicrobial agent is included in the treatment formulation for its obvious properties of preventing infectious substances and vectors from contaminating patients and others. As a class, members of the organosilicones (a preferred group of antimicrobial agents) exhibit antimicrobial activity and have the required regulatory clearances for use in hospital and medical fabrics The preferred organosilicone antimicrobial is 3-(trimethoxysilyl)-propyloctadecyldimethyl ammonium chloride. A class of suitable bioactive organosilicone compounds have the formula:
(CH3)2 (cH3otsi~cH2)N+ R
Rl -in which R is a Cll_22 alkyl group and R is chlorine or bromine The preferred silicone quaternary amine ~3~3~42 is 3-(trimethoxysilyl)- propyloctadecyl dimethyl ammonium chloride (R = Cl8H38, R = Cl) which is described in U.S. Patent No. 3,730,701, the disclosure of which is hereby incorporated by reference, and is available as a 42% active solids in methanol from Dow Corning Corporation of Midland, Michigan under the designation DC-5700 or Sylgard 5700. This material is well accepted in commerce and has been approved not only as a bacteriostatic textile treatment but also as a bactericidal component for medical device/non-drug applications.
Another suitable antimicrobial is Sanitized Plus (Sandoz) also an organosilicone.
The quantity of antimicrobial agent included in the pad bath formulation is dependent upon its durability to laundering and the degree of antimicrobial protection desired. Generally, the amount will be in the range of from about 0.5 to about 5.0% calculated on the weight of the entire mix.
Antistatic compounds may be included in the pad bath to enable the treated fabric to dissipate static electricity, particularly in surgical environments where combustible gases are present. Suitable antistats are quaternary ammonium compounds, such as Aerotex CSN (American Cyanamid), and the alkyl amines, such as Aston 123 (Hi-Tek Polymers).
Medical fabrics are usually dyed to give them a pleasing appearance and to color code the level of use to which the product is suited Dyes present in the pad bath must remain on the fabric and resist crocking and bleeding even following multiple institutional laundering and autoclaving. Disperse 1313~42 dyes satisfy these requirements. Citric acid may be used in the bath to lower the pH and thus to assist dyeing.
The above is a typical pad bath formulation.
The amount of bath of this general formulation applied to and taken up by the fabric is usually in the range of from about 40% to about 100% and is expressed on the weight of the fabric. For the above formulation, the ingredients are added to the required quantity of water in the following order:
citric acid, surfactant, disperse dye, organosilicone compound (previously pre-diluted 50%3, antistatic compound, fluorocabron water repellent and flame retardant.
After the fabric is treated with the aqueous formulation, it is dried to remove moisture before further processing.
The dried, treated fabric is then passed between a set of heated ~about 300~ to 400F) steel rolls and pressed with force sufficient to lower the air permeability of the fabric. Calendering gives the polyester yarn permanent mechanical properties, makes the fabric more dense thereby lowering air permeability without adding to the cost of construction. It closes the interstitial pores and flattens the fabric surface. The effect of calendering is measured by air permeability of the treated fabric. An air permeability of between about 0.5 and 2.0 cfm (Frazier method) is required for most fabric applications. Calendering is an optional but cost saving process, and enables the use of a less densely constructed fabric. Calendering temperatures must exceed the washing, drying and autoclaving ~313:342 temperatures the finished medical fabric will experience in use. Generally the fabric must be exposed to a temperature of at least 300F; the upper limit is set by the melting point of the polyester fibers or the scorch point of the applied finish. As a practical matter, the upper limit will be about Pressure applied to the fabric during calendering usually falls within the range of about 500 to 4,000 pounds per linear inch, preferably about 1,000 to about 2,000 pounds per linear inch, and generally the higher pressure the better. Generally, two c~lendering passes are used. The necessity for calendering for a specific fabric construction is determined by satisfying the target Frazier air permeability values, as explained above.
EXAMPLE
A woven medical fabric suitable for making an isolation gown was prepared from woven 70 denier, 34 filament 100% polyester yarn woven in a plain weave pattern with a final construction of 146 ends and 85 picks per inch and a weight of 2.47 ounces per yard.
The greige fabric was washed, processed to remove all 13~3342 foreign substances and debris, then dried. The fabric was padded and treated in a pad bath containing:
water 50~
citric acid 0.1 lb.
igopropyl alcohol 4 lb.
di~per~e dye Pananil Yellow P-6G O.Z5 lb.
Dow-Corning 5700 antimicrobial Iprediluted with water 1~11 4 lb.
Aerotex CSN
lAmerican Cyanimid) antigtat 4 lb.
Zonyl NWG IDuPont) 20 lb.
to make 50 gallons. The pad bath was applied at ambient temperature at a speed of 60 yards per minute with a wet pick-up of 55% calculated on the weight of the fabric.
The fabric was then dried in a single pass in a tenter frame with a dwell time of from 30 to 60 seconds at about 425F. Next the treated fabric was calendered at a speed of 40 yards per minute in a double nip steel over fiber roll with a surface temperature at about 350F and at a pressure of about 1,500 pounds per linear inch.
The finished isolation gown fabric had the following properties:
Fabric Con3truction width (inches 1 63.1 weight loz~yd ) 2.47 pick~ per inch 85 ends per inch 146 Properties tensile, warp Ilbs) 164 ASIM 1682 tensile, fill Ilbs) 115 AS111 1682 air porosity Icfm~ 0.1~7 FIM-5450 Suter hydrostatic Icm) 35.5 MTCC-127 spray 90 AATCC-22-1980 oil repellency 4 INDA 80.8 alcohol repellency 9 INDA 80.9 water impact Ig. ) O.Z5 AAlCC 4Z-1974 bioactivity 100% Dow Corning-CT11-0963 static decay, warp 1~10.13 I-~0.11 NFPA 99 Isec. ), f ill I ~)O.ZI I - )0.18 NFPA 99 crockfastness wet 5.0 AATCC-8-1980 dry 5.0 AATCC-8-1980 flammability warp Class II NFPA-7ûZ
fill Clas~ II IIFPA-702 While we have presented a number of embodiments of this invention, it is apparent that our basic constructions and finishes can be altered to provide 13~3342 other embodiments which utilize the processes and compositions of this invention. The reader will appreciate that the scope of this invention is to be defined by the claims appended here to rather than the specific embodiments and illustrations which have been presented above by way of example.
80.9. Initial values should be an absolute value o at least 6 (on a scale of 0-lO) but can be expected to decrease following multiple launderings 10. Air permeability - Frazier method - is used to assess the barrier properties of the fabric usually during production. Air permeability of less than 5 initially and at most 10 cubic feet per minute per square foot of fabric sample at 0.5 inch water after 100 laundry cycles measured according to Federal Test Method FTM 5450.
-These and related properties may be assessedusing diverse testing methods and quantification procedures, and evaluations may be made following any given number of washing/drying or laundry/
sterilization cycles The medical fabric of this invention may have essentially two performance levels Medical garments 1313~42 or products subjected to institutional washing and drying operations constructed from medical fabrics of this invention are quite satisfactory and represent an advancement when their water repellency is a minimum of 20 as tested on Suter hydrostatic test AATCC 127 initially. Other types of medical products and apparel require a higher level (on the order of 30 cm Suter hydrostatic test) to provide a satisfactory level of repellency.
7 ~313;~42 After 100 laundering and autoclave sterilization cycles, these ~-alues are as follows:
Initial After 100 Cycles Linting 5000 Max. 2000 Max IINDA 160-0-83~
Flammability Clags II Class II
(NFPA 702~
* at least 3 0 I~NDA ~8.8) Antimicrobial Activity No Growth No Growth ICIM-0923) Klebsiella Pneumoniae Alcohol Repellency*
at least 6 0 (INDA 80.9) Suter Hydrostatic 20.0 10.00 IAATCC-127), cm.
Spray Rating at least 70 at least 50 I M TCC-22-1980) Frazier Air Permeability less than S less than 10 IFTM 5450) cfmYft ~ 1/2" H20 *
optional properties 1313~42 Fabric construction is important to a successful product. The medical fabric used in this invention is woven from 100% polyester filament yarn (nylon lacks durability and is unsuited to this invention) with an optimum, predetermined fabric density.
Fabric density is a function of the fabric construction in which yarn denier, number of ends and number of picks (thread count) per linear inch are the essential variables. For general purposes, the yarn denier will fall in the range of from 50 to 150 in combination with a sum of the ends and picks (sometimes called a "round count") of at least 100 per inch. The following Table will provide guidance for appropriate range of fabric construction.
Denier Ends Picks Max. 50 162 108 Min. 50 108 72 Max. 70 137 191 Min. 70 190 60 Max. 100 116 76 Min. 100 76 50 Max. 150 94 62 Min. 150 62 42 131~342 The woven fabric, prior to finishing, has a weight of from about 2 to 10 ounces per square yard, preferably 2 to 3 ounces per square yard with 2.5 the most desired value.
Prior to treating, we recommend washing, drying and otherwise removing any lint that may be attached to or embedded in the fabric.
The polyester woven fabric of appropriate construction is finished with a treatment bath which may be applied using any convenient textile finishing operation and textile finishing equipment. Our equipment and experiences are specific to applying the treatment from a pad bath followed by subsequent processing in open width as explained in more detail below. Other methods of application including spraying, brushing, exhaust, etc., readily recognized by those skilled in this art may be used.
In overview, the pad bath contains the following types of ingredients; some listed below are optional ingredients, as indicated:
~313342 _n~redientAmount Iwt. %l non-rewetting surfactant .OZ5 - 2.0 fluorocarbon water repellentZ.0 - 15.0 flame retardant ~.0 - 20.0 antimicrobial agent 0.5 - 5.0 antistatlc compound 0.5 - 10.0 citric acid 0.01 - 1.0 disperse dye 0.01 - 3.0 pad pickup ~o~fl 40 ~ 100%
*
optional 11 131~342 Components of the pad bath serve various purposes and are readily available from several commercial sources.
Surfactants, to lower the surface tension of the water, a major ingredient of the bath, suited to the invention are of the non-rewetting type. The following surfactants are suggested: fatty acid amines, Mykon NRW3 (Sequa); alcohols, Penetrant KB
(Burlington Industries, Chemical Division); nonionic emulsions, Alkanol 6112 and Avitex 2153 (DuPont).
The fluQrocarbon water repellent component is typically a dispersion of fluoropolymer in water (see generally Fluorine-Containing Polymers, Encyclopedia of Polymer Science & Technology, pp 179-203, Interscience, 1967, the disclosure of which is hereby incorporated by reference). The fluoropolymer component may be selected from a host of commercially available products including DuPont's Zonyl NWG, Zonyl NWN, Zepel 6700, and 3-M's FC-834, FC-461 and FC 232. It is the fluorocarbon component that provides the water and fluid repellency to the finished fabric. One will select a repellent fluorocarbon component that is compatible with the system, i.e., the other bath components and processing conditions, is economical and provides the required degree of liquid repellency. A wax extender for the fluorocarbon may be incorporated in the formulation as required.
Flame retardants may be included in the formulation to impart flame resistance to the treated fabric. A variety of flame retardants are commercially available for cotton, synthetic and cotton/synthetic blended fabrics We find those 131:~342 1ame retardants convenient that can be added to a single finish formulation and do not require a separate processing step or steps to attach the flame retardant to the fibers. A preferred class of flame retardants are the cyclic phosphonate esters, a group of known flame retardants as described in U.S. Patent Nos. 3,789,091 and 3,849,368. Antiblaze 19 and Antiblaze l9T are commercially available cyclic phosphonate ester flame retardants from Albright &
Wilson. Other flame retardants suitable for this invention are Glo-Tard NTB (Glo-Tex) and Flameproof #1525 (Apex); all are organophosphates.
An antimicrobial agent is included in the treatment formulation for its obvious properties of preventing infectious substances and vectors from contaminating patients and others. As a class, members of the organosilicones (a preferred group of antimicrobial agents) exhibit antimicrobial activity and have the required regulatory clearances for use in hospital and medical fabrics The preferred organosilicone antimicrobial is 3-(trimethoxysilyl)-propyloctadecyldimethyl ammonium chloride. A class of suitable bioactive organosilicone compounds have the formula:
(CH3)2 (cH3otsi~cH2)N+ R
Rl -in which R is a Cll_22 alkyl group and R is chlorine or bromine The preferred silicone quaternary amine ~3~3~42 is 3-(trimethoxysilyl)- propyloctadecyl dimethyl ammonium chloride (R = Cl8H38, R = Cl) which is described in U.S. Patent No. 3,730,701, the disclosure of which is hereby incorporated by reference, and is available as a 42% active solids in methanol from Dow Corning Corporation of Midland, Michigan under the designation DC-5700 or Sylgard 5700. This material is well accepted in commerce and has been approved not only as a bacteriostatic textile treatment but also as a bactericidal component for medical device/non-drug applications.
Another suitable antimicrobial is Sanitized Plus (Sandoz) also an organosilicone.
The quantity of antimicrobial agent included in the pad bath formulation is dependent upon its durability to laundering and the degree of antimicrobial protection desired. Generally, the amount will be in the range of from about 0.5 to about 5.0% calculated on the weight of the entire mix.
Antistatic compounds may be included in the pad bath to enable the treated fabric to dissipate static electricity, particularly in surgical environments where combustible gases are present. Suitable antistats are quaternary ammonium compounds, such as Aerotex CSN (American Cyanamid), and the alkyl amines, such as Aston 123 (Hi-Tek Polymers).
Medical fabrics are usually dyed to give them a pleasing appearance and to color code the level of use to which the product is suited Dyes present in the pad bath must remain on the fabric and resist crocking and bleeding even following multiple institutional laundering and autoclaving. Disperse 1313~42 dyes satisfy these requirements. Citric acid may be used in the bath to lower the pH and thus to assist dyeing.
The above is a typical pad bath formulation.
The amount of bath of this general formulation applied to and taken up by the fabric is usually in the range of from about 40% to about 100% and is expressed on the weight of the fabric. For the above formulation, the ingredients are added to the required quantity of water in the following order:
citric acid, surfactant, disperse dye, organosilicone compound (previously pre-diluted 50%3, antistatic compound, fluorocabron water repellent and flame retardant.
After the fabric is treated with the aqueous formulation, it is dried to remove moisture before further processing.
The dried, treated fabric is then passed between a set of heated ~about 300~ to 400F) steel rolls and pressed with force sufficient to lower the air permeability of the fabric. Calendering gives the polyester yarn permanent mechanical properties, makes the fabric more dense thereby lowering air permeability without adding to the cost of construction. It closes the interstitial pores and flattens the fabric surface. The effect of calendering is measured by air permeability of the treated fabric. An air permeability of between about 0.5 and 2.0 cfm (Frazier method) is required for most fabric applications. Calendering is an optional but cost saving process, and enables the use of a less densely constructed fabric. Calendering temperatures must exceed the washing, drying and autoclaving ~313:342 temperatures the finished medical fabric will experience in use. Generally the fabric must be exposed to a temperature of at least 300F; the upper limit is set by the melting point of the polyester fibers or the scorch point of the applied finish. As a practical matter, the upper limit will be about Pressure applied to the fabric during calendering usually falls within the range of about 500 to 4,000 pounds per linear inch, preferably about 1,000 to about 2,000 pounds per linear inch, and generally the higher pressure the better. Generally, two c~lendering passes are used. The necessity for calendering for a specific fabric construction is determined by satisfying the target Frazier air permeability values, as explained above.
EXAMPLE
A woven medical fabric suitable for making an isolation gown was prepared from woven 70 denier, 34 filament 100% polyester yarn woven in a plain weave pattern with a final construction of 146 ends and 85 picks per inch and a weight of 2.47 ounces per yard.
The greige fabric was washed, processed to remove all 13~3342 foreign substances and debris, then dried. The fabric was padded and treated in a pad bath containing:
water 50~
citric acid 0.1 lb.
igopropyl alcohol 4 lb.
di~per~e dye Pananil Yellow P-6G O.Z5 lb.
Dow-Corning 5700 antimicrobial Iprediluted with water 1~11 4 lb.
Aerotex CSN
lAmerican Cyanimid) antigtat 4 lb.
Zonyl NWG IDuPont) 20 lb.
to make 50 gallons. The pad bath was applied at ambient temperature at a speed of 60 yards per minute with a wet pick-up of 55% calculated on the weight of the fabric.
The fabric was then dried in a single pass in a tenter frame with a dwell time of from 30 to 60 seconds at about 425F. Next the treated fabric was calendered at a speed of 40 yards per minute in a double nip steel over fiber roll with a surface temperature at about 350F and at a pressure of about 1,500 pounds per linear inch.
The finished isolation gown fabric had the following properties:
Fabric Con3truction width (inches 1 63.1 weight loz~yd ) 2.47 pick~ per inch 85 ends per inch 146 Properties tensile, warp Ilbs) 164 ASIM 1682 tensile, fill Ilbs) 115 AS111 1682 air porosity Icfm~ 0.1~7 FIM-5450 Suter hydrostatic Icm) 35.5 MTCC-127 spray 90 AATCC-22-1980 oil repellency 4 INDA 80.8 alcohol repellency 9 INDA 80.9 water impact Ig. ) O.Z5 AAlCC 4Z-1974 bioactivity 100% Dow Corning-CT11-0963 static decay, warp 1~10.13 I-~0.11 NFPA 99 Isec. ), f ill I ~)O.ZI I - )0.18 NFPA 99 crockfastness wet 5.0 AATCC-8-1980 dry 5.0 AATCC-8-1980 flammability warp Class II NFPA-7ûZ
fill Clas~ II IIFPA-702 While we have presented a number of embodiments of this invention, it is apparent that our basic constructions and finishes can be altered to provide 13~3342 other embodiments which utilize the processes and compositions of this invention. The reader will appreciate that the scope of this invention is to be defined by the claims appended here to rather than the specific embodiments and illustrations which have been presented above by way of example.
Claims (31)
1. A woven, reusable, launderable and sterilizable polyester fabric constructed from polyester yarn of from about 50 to 150 denier and a sum of the ends and picks of at least 100 per linear inch having the following properties initially and following 100 laundering cycles:
2. The woven fabric of claim 1, in which the fabric has a Suter hydrostatic resistance of at least 35.0 initially and at least 20.0 after 100 cycles.
3. The woven fabric of claim 2, in which the fabric has a Suter hydrostatic resistance of at least 50.0 initially.
4. The woven fabric of claim 1, in which the fabric has an initial oil repellency (INDA 80.8) of at least 3.
5. The woven fabric of claim 1, in which the fabric has an initial alcohol repellency (INDA 80.9) of at least 6.
6. The woven fabric of claim 1, in which the fabric has a spray rating (AATCC-22-1980) of at least 70.
7. A woven isolation gown, surgical gown, surgical scrub suit, sterilization wrapper, cover gown, isolation gown, hamper bag, jump suit, work apron or laboratory coat constructed of the fabric of any one of claims 1, 2, 4, 5 or 6.
8. A woven polyester medical fabric constructed from polyester yarn of about 50 to about 150 denier and a sum of ends and picks of at least 100 per linear inch having the following properties initially and following 100 laundering and steam sterilization cycles:
9. The woven medical fabric of claim 8, in which the fabric has an initial Suter hydrostatic resistance of at least 50Ø
10. The woven medical fabric of claim 8, in which the fabric has an initial oil repellency (INDA
80.8) of at least 3.
80.8) of at least 3.
11. The woven medical fabric of claim 8, in which the fabric has an initial alcohol repellency (INDA 80.9) of at least 6.
12. The woven medical fabric of claim 8, in which the fabric has a spray rating (AATCC-22-1980) of at least 70.
13. A woven, reusable, launderable and sterilizable isolation gown, surgical gown, surgical scrub suit, sterilization wrapper, cover gown, isolation gown, hamper bag, jump suit, work apron or laboratory coat constructed of the medical fabric of any one of claims 8, 9, 10, 11 or 12.
14. A process of imparting water-resistent, flame-resistant, and low linting properties to a tightiy woven medical fabric comprising the steps of:
(1) applying to a woven polyester fabric, constructed from polyester yarn of about 50 to about 150 denier with the sum of ends and picks of at least 100 per linear inch, an aqueous finish composition containing a fluorocarbon water repellent and a flame retardant and (2) drying the fabric, the resulting medical fabric having the following properties initially and following 100 laundering cycles:
(1) applying to a woven polyester fabric, constructed from polyester yarn of about 50 to about 150 denier with the sum of ends and picks of at least 100 per linear inch, an aqueous finish composition containing a fluorocarbon water repellent and a flame retardant and (2) drying the fabric, the resulting medical fabric having the following properties initially and following 100 laundering cycles:
15. The process of claim 14, in which the resulting medical fabric has a Suter hydrostatic resistance of at least 35.0 initially and at least 20.0 after 100 cycles.
16. The process of claim 15, in which the resulting medical fabric has a Suter hydrostatic resistance of at least 50.0 initially.
17. The process of claim 14, in which the resulting medical fabric has an initial oil repellency (INDA 80.8) of at least 3.
18, The process of claim 14, in which the resulting medical fabric has an initial alcohol repellency (INDA 80.9) of at least 6.
19. The process of claim 14, in which the resulting medical fabric has a spray rating (AATCC-27-1980) of at least 70.
20. The process of claim 14, including the additional step of (3) calendering the fabric at a temperature of at least 300°F with a force sufficient to reduce the air permeability of the fabric to at most 2.0 cubic feet per minute per square foot (Frazier method).
21. The process of claim 20, in which the fabric is calendered at a pressure of from about 500 to about 4,000 pounds per linear inch.
22. The process of claim 20 , in which the fabric is calendered at a pressure of about 1,000 to about 2,000 pounds per linear inch.
23. A woven, launderable, and sterilizable medical fabric having the following properties initially and following 100 laundering cycles:
24. A process of imparting water-resistant flame-resistant, and low limiting properties to a tightly woven medical fabric comprising the steps of:
(1) applying to a woven polyester fabric constructed from polyester yarn of about 50 to about 150 denier with the sum of ends and picks of at least 100 per linear inch, an aqueous finish composition containing a fluorocarbon water repellent, and a flame retardant, and (2) drying the fabric, the resulting medical fabric having the following properties initially and following 100 laundering and steam sterilization cycles:
(1) applying to a woven polyester fabric constructed from polyester yarn of about 50 to about 150 denier with the sum of ends and picks of at least 100 per linear inch, an aqueous finish composition containing a fluorocarbon water repellent, and a flame retardant, and (2) drying the fabric, the resulting medical fabric having the following properties initially and following 100 laundering and steam sterilization cycles:
25. The process of claim 14, in which the resulting medical fabric has an initial oil repellency (INDA 80.8) of at least 3.
26. The process of claim 14, in which the resulting medical fabric has an initial alcohol repellency (INDA 80.9) of at least 6.
27. The process of claim 14, in which the resulting medical fabric has a spray rating (AATCC-27-1980) of at least 70.
28. The process of claim 24, including the additional step of (3) calendering the fabric at a temperature of at least 300°F with a force sufficient to reduce the air permeability of the fabric to at most 2.0 cubic feet per minute per square foot (Frazier method).
29. The process of claim 28, in which the fabric is calendered at a pressure of from about 500 to about 4,000 pounds per linear inch.
30. The process of claim 29, in which the fabric is calendered at a pressure of about 1,000 to about 2,000 pounds per linear inch.
31. A woven, launderable, and sterilizable medical fabric having the following properties initially and following 100 laundering and steam sterilization cycles:
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US164,197 | 1988-03-04 | ||
US07/164,197 US4822667A (en) | 1988-03-04 | 1988-03-04 | Woven medical fabric |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1313342C true CA1313342C (en) | 1993-02-02 |
Family
ID=22593406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000583707A Expired - Fee Related CA1313342C (en) | 1988-03-04 | 1988-11-22 | Woven medical fabric |
Country Status (6)
Country | Link |
---|---|
US (1) | US4822667A (en) |
EP (1) | EP0330783B1 (en) |
AT (1) | ATE116697T1 (en) |
AU (1) | AU620826B2 (en) |
CA (1) | CA1313342C (en) |
DE (1) | DE3852699T2 (en) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5024851A (en) * | 1988-03-04 | 1991-06-18 | Precision Fabrics Group Inc. | Process for preparing a woven medical fabric |
US4898957A (en) * | 1988-04-18 | 1990-02-06 | Dow Corning Corporation | Organosilicon diamine antimicrobial compound |
US5126138A (en) * | 1988-07-19 | 1992-06-30 | Dow Corning Corporation | Antimicrobial flourochemically treated plastic (nylon) surfaces |
US5073298A (en) * | 1988-07-20 | 1991-12-17 | Dow Corning Corporation | Antimicrobial antifoam compositions and methods |
US4977016B1 (en) * | 1988-10-28 | 1998-03-03 | Stern & Stern Ind Inc | Low permeability fabric and method of making same |
US5145596A (en) * | 1989-08-07 | 1992-09-08 | Dow Corning Corporation | Antimicrobial rinse cycle additive |
US5064613A (en) * | 1989-11-03 | 1991-11-12 | Dow Corning Corporation | Solid antimicrobial |
US5013459A (en) * | 1989-11-09 | 1991-05-07 | Dow Corning Corporation | Opthalmic fluid dispensing method |
US5424117A (en) * | 1990-06-29 | 1995-06-13 | Standard Textile Co. Inc. | Fabrics for surgical gowns and the like and method of making same and textile products made therefrom |
GB2254476A (en) * | 1991-03-20 | 1992-10-07 | Plant J W & Co Ltd | Flurocarbon treatment of flags |
US5244718A (en) * | 1991-04-03 | 1993-09-14 | Taylor Jeffrey L | Synthetic fabrics and surgical/medical products made therefrom |
NZ242211A (en) * | 1991-04-03 | 1995-03-28 | Jeffrey Lynn Taylor | Tightly woven synthetic fabric for use in reusable surgical and medical products |
JPH04370240A (en) * | 1991-06-17 | 1992-12-22 | Teijin Ltd | Hospital textile |
EP0662537A1 (en) * | 1994-01-08 | 1995-07-12 | MEWA Textil-Service AG | Textile cloth |
US6239048B1 (en) | 1994-12-28 | 2001-05-29 | Fibermark, Inc. | Light-activated antimicrobial and antiviral materials |
US6492001B1 (en) * | 1996-08-07 | 2002-12-10 | Hi-Tex, Inc. | Treated textile fabric |
WO1996039032A1 (en) * | 1995-06-06 | 1996-12-12 | Kimberly-Clark Worldwide, Inc. | Microporous fabric containing a microbial adsorbent |
US5912196A (en) * | 1995-12-20 | 1999-06-15 | Kimberly-Clark Corp. | Flame inhibitor composition and method of application |
US6632805B1 (en) | 1996-05-07 | 2003-10-14 | Emory University | Methods for using water-stabilized organosilanes |
US5959014A (en) | 1996-05-07 | 1999-09-28 | Emory University | Water-stabilized organosilane compounds and methods for using the same |
US6251210B1 (en) * | 1996-08-07 | 2001-06-26 | Hi-Tex, Inc. | Treated textile fabric |
CA2283865C (en) | 1997-01-21 | 2006-06-13 | Pamela C. Wang | Weaving reed dent spacing arrangements |
US5954869A (en) | 1997-05-07 | 1999-09-21 | Bioshield Technologies, Inc. | Water-stabilized organosilane compounds and methods for using the same |
US6762172B1 (en) | 1997-07-17 | 2004-07-13 | Nova Biogenetics, Inc. | Water-stabilized organosilane compounds and methods for using the same |
US6113815A (en) * | 1997-07-18 | 2000-09-05 | Bioshield Technologies, Inc. | Ether-stabilized organosilane compositions and methods for using the same |
US6277770B1 (en) | 1997-10-08 | 2001-08-21 | Precision Fabrics Group, Inc. | Durable, comfortable, air-permeable allergen-barrier fabrics |
EP0908122B1 (en) | 1997-10-08 | 2004-04-28 | Precision Fabrics Group, Inc. | Durable, comfortable, air-permeable allergen-barrier fabrics |
AU781497B2 (en) * | 1997-10-20 | 2005-05-26 | Yenkuen Hsiao | Porous formed article capable of killing or inhibiting the harmful microbes as well as its fabrication methodology |
US5920929A (en) * | 1997-12-01 | 1999-07-13 | Henwood Corporation | Immobile-patient transfer device |
WO1999054530A1 (en) | 1998-04-20 | 1999-10-28 | Bba Nonwovens Simpsonville, Inc. | Nonwoven fabric having both uv stability and flame retardancy and related method for its manufacture |
AU6283199A (en) * | 1998-10-02 | 2000-04-26 | Precision Fabrics Group, Inc | Durable, comfortable, air-permeable allergen-barrier fabrics |
US6374828B1 (en) | 2000-03-02 | 2002-04-23 | Standard Textile Co., Inc. | Single wrap, two-ply reusable surgical wrapper |
US6759127B1 (en) * | 2001-09-27 | 2004-07-06 | Precision Fabrics Group, Inc. | Treated inherently flame resistant polyester fabrics |
US20040261373A1 (en) * | 2003-03-10 | 2004-12-30 | Polymer Group, Inc. | Method of using medical wrap in continuous form |
US20040185728A1 (en) * | 2003-03-21 | 2004-09-23 | Optimer, Inc. | Textiles with high water release rates and methods for making same |
US7399519B2 (en) * | 2003-09-22 | 2008-07-15 | Milliken & Company | Treated textiles and compositions for treating textiles |
US7752680B2 (en) * | 2004-09-02 | 2010-07-13 | Standard Textile Co., Inc. | Protective-apparel sleeve and protective apparel incorporating same |
US20060041989A1 (en) * | 2004-09-02 | 2006-03-02 | Bushman Bradley J | Liquid-proof sleeve and protective apparel incorporating same |
US7208202B2 (en) * | 2004-11-18 | 2007-04-24 | Precision Fabrics Group, Inc. | Methods of finishing medical barrier fabrics |
US7802313B2 (en) * | 2005-07-12 | 2010-09-28 | Medline Industries, Inc. | Surgical gowns and other protective apparel having color-coding for identifying barrier protection levels and methods of making same |
US7531219B2 (en) * | 2005-07-21 | 2009-05-12 | Hi-Tex, Inc. | Treated textile fabric |
US20090226495A1 (en) * | 2007-07-17 | 2009-09-10 | Picardi Salvatore Charles | Nanodiamond enhanced efficacy |
US20080120783A1 (en) * | 2006-08-17 | 2008-05-29 | Warren Francis Knoff | Nanofiber allergen barrier fabric |
US20110039468A1 (en) * | 2009-08-12 | 2011-02-17 | Baldwin Jr Alfred Frank | Protective apparel having breathable film layer |
US9360351B2 (en) * | 2011-10-18 | 2016-06-07 | Bekaert Textiles Nv | Bed monitoring device |
EP2641578B1 (en) * | 2012-03-22 | 2016-01-20 | Arjo Hospital Equipment AB | Patient sling |
CN103437176A (en) * | 2013-07-19 | 2013-12-11 | 东华大学 | Low-carbon preparation method of one-way-moisture-conduction pure cotton clothing fabric |
CN103556352A (en) * | 2013-10-17 | 2014-02-05 | 苏州威尔德工贸有限公司 | Anti-static inflaming retarding fabric |
WO2019036680A1 (en) * | 2017-08-18 | 2019-02-21 | Judah Greg | Textiles treated with composition inhibiting sustainability and growth of pathogenic microbes |
CN108708101A (en) * | 2018-05-31 | 2018-10-26 | 海宁市丁桥镇永畅知识产权服务部 | A kind of production method of flame-proof antibiotic sheet fabric |
DE102021118670A1 (en) * | 2020-07-20 | 2022-01-20 | TanMeOn GmbH | UV-A and UV-B permeable fabric |
US20220205170A1 (en) * | 2020-12-28 | 2022-06-30 | Standard Textile Co., Inc. | Coated barrier fabric for a reusable medical product |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4286012A (en) * | 1979-12-17 | 1981-08-25 | Angelica Corporation | Long wetting time woven fabric |
US4561434A (en) * | 1983-09-06 | 1985-12-31 | Standard Textile Co., Inc. | Launderable cloth-like product for surgical use and method of making the same |
US4525409A (en) * | 1983-09-19 | 1985-06-25 | Flexi-Mat Corporation | Nylon or polyester treated fabric for bedding |
EP0153155B1 (en) * | 1984-02-16 | 1991-03-20 | Teijin Limited | Dust-proof fabric |
DE3627391C1 (en) * | 1986-08-13 | 1987-12-03 | Schneeweiss 1882 Otto Und Andr | Process for finishing textile operating theatre material, in particular patients' drapes and surgical gowns |
-
1988
- 1988-03-04 US US07/164,197 patent/US4822667A/en not_active Expired - Lifetime
- 1988-11-21 AT AT88310985T patent/ATE116697T1/en not_active IP Right Cessation
- 1988-11-21 DE DE3852699T patent/DE3852699T2/en not_active Expired - Fee Related
- 1988-11-21 EP EP88310985A patent/EP0330783B1/en not_active Expired - Lifetime
- 1988-11-22 CA CA000583707A patent/CA1313342C/en not_active Expired - Fee Related
- 1988-11-24 AU AU25900/88A patent/AU620826B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0330783B1 (en) | 1995-01-04 |
DE3852699T2 (en) | 1995-06-01 |
EP0330783A3 (en) | 1990-08-22 |
DE3852699D1 (en) | 1995-02-16 |
EP0330783A2 (en) | 1989-09-06 |
ATE116697T1 (en) | 1995-01-15 |
AU620826B2 (en) | 1992-02-27 |
AU2590088A (en) | 1989-09-07 |
US4822667A (en) | 1989-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1313342C (en) | Woven medical fabric | |
US5024851A (en) | Process for preparing a woven medical fabric | |
US4919998A (en) | Woven medical fabric | |
US20060228964A1 (en) | Fabric treated with durable stain repel and stain release finish and method of industrial laundering to maintain durability of finish | |
Schindler et al. | Chemical finishing of textiles | |
AU717830B2 (en) | Method and means for increasing efficacy and wash durability of insecticide treated fabric | |
US8803115B2 (en) | Coated microfibrous web and method for producing the same | |
US8793814B1 (en) | Flame resistant fabric made from a fiber blend | |
US20200360735A1 (en) | Water Resistant Protective Garment | |
US20220160059A1 (en) | Protective Garment Having Antiviral Properties in Combination with Water Resistance | |
JP2006515905A (en) | Textile finishes containing fluorochemicals exhibiting wash-resistant soil release and moisture absorption properties | |
EP4043638A1 (en) | Coated barrier fabric for a reusable medical product | |
JP2004346467A (en) | Pollen-preventive fabric | |
JP5755976B2 (en) | Medical fabric | |
KR101004245B1 (en) | Compositions and treated substrates having reversibly adaptable surface energy properties and method for making the same | |
Hobbs et al. | Effects of barrier finishes on aerosol spray penetration and comfort of woven and disposable nonwoven fabrics for protective clothing | |
Samui et al. | Care, maintenance and disposability of medical and protective textile products | |
CA1299355C (en) | Non-linting, anti-static surgical fabric articles | |
Nguyen | Multifunctional smart textiles: influences of hydrophobic additional finishes on antimicrobial treated cotton fabric | |
US20230276880A1 (en) | Protective Garment Having Water and Oil Resistance | |
JPH0827671A (en) | Production of fiber structure having mite repellent effect | |
Kishwar | Investigations related to hydrodynamic characteristics and safety profile of surgical gowns | |
WO2024050034A2 (en) | Garment treatment and method of application thereof | |
JP4240911B2 (en) | Fabric for sterilization resistance | |
Mohammed | Healthcare workers uniforms (HCWU) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |